Approval · Notice of Compliance 18971 · 2017
PRISTIQ: Notice of Compliance 18971
Issued January 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18971
- Date
- January 27, 2017
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Introduction of new carton design for 50 mg physician samples
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRISTIQ | Not yet assigned | — |
Medicinal ingredients
- DESVENLAFAXINE SUCCINATE 50 MG per TAB
- DESVENLAFAXINE SUCCINATE 100 MG per TAB